Sarepta Therapeutics, Inc.
(NASDAQ : SRPT)

( )
SRPT PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.58%177.120.7%$1156.59m
LLYEli Lilly & Co. 0.96%372.061.1%$1068.92m
MRKMerck & Co., Inc. 1.06%110.080.7%$1002.54m
PFEPfizer Inc. 1.09%50.250.9%$935.84m
ABBVAbbVie, Inc. 0.98%165.321.9%$895.13m
BMYBristol-Myers Squibb Co. 0.01%79.931.1%$742.00m
AZNAstraZeneca Plc 0.42%68.851.0%$354.37m
HZNPHorizon Therapeutics Plc -0.57%96.305.4%$286.44m
GSKGSK Plc -2.74%36.880.3%$251.05m
IDXXIDEXX Laboratories, Inc. 1.13%420.103.9%$191.38m
NVSNovartis AG 1.09%91.730.2%$188.48m
CTLTCatalent, Inc. -2.05%47.231.9%$170.45m
ALNYAlnylam Pharmaceuticals, Inc. 5.32%231.338.0%$168.15m
NVONovo Nordisk A/S -0.42%125.260.1%$152.07m
SNYSanofi -1.26%47.940.2%$138.09m

Company Profile

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.